EANM

EANM: Thomas Hope on what’s next in FAP-targeted theranostics
By Will Morton
The innovations and work being done to optimize FAP agents will likely "spill over" to other targets.
October 19, 2026
Clinical research presentation slide showing FAP RLT experience data table with patient outcomes across multiple institutions and speaker photo
EANM: Affibody presents data on HER2 radioligand therapy
By AuntMinnieEurope.com staff writers
The Stockholm, Sweden-based company is highlighting progress across its radiopharmaceutical pipeline.
October 19, 2026
A26 NMM World Leading Meeting event branding overlaid on aerial cityscape at sunset
EANM: Akiram presents first clinical data for CD44v6-targeted therapy
By AuntMinnieEurope.com staff writers
The first-in-human ongoing phase I trial is evaluating Lu-177 AKIR001 in patients with irresectable or metastatic CD44v6-positive solid tumors.
October 19, 2026
A26 NMM World Leading Meeting event branding overlaid on aerial cityscape at sunset
EANM: Next-generation PET scanner cuts imaging time to one minute
By Will Morton
The scanner's fastest images were rated more highly on average than those from a standard PET/CT scanner.
October 18, 2026
PET scan comparison showing SAFOV baseline and 1-minute and 5-minute time-point imaging with tracer uptake patterns
Page 1 of 1